Patents by Inventor Matthew Hohenboken

Matthew Hohenboken has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8232072
    Abstract: Described are smoking cessation devices and kits for determining an advantageous time for a subject to quit smoking, and/or for extending the duration of smoking abstinence, based on serum levels of anti-nicotine antibodies. Related methods are also described.
    Type: Grant
    Filed: June 9, 2009
    Date of Patent: July 31, 2012
    Assignee: Nabi Biopharmaceuticals
    Inventors: Matthew Kalnik, Matthew Hohenboken, Paul Kessler, Ali Fattom, Raafat Fahim, Leslie Hudson
  • Publication number: 20110182918
    Abstract: Described are smoking cessation devices and kits for determining an advantageous time for a subject to quit smoking, and/or for extending the duration of smoking abstinence, based on serum levels of anti-nicotine antibodies, and personalized drug treatment methods, including methods and kits for the treatment and prevention of drug addiction, drug use and drug abuse, which include determining the subject's pre-vaccine levels of antibodies specific for the drug hapten at issue. Related methods are also described.
    Type: Application
    Filed: December 16, 2010
    Publication date: July 28, 2011
    Inventors: Matthew Kalnik, Matthew Hohenboken, Paul Kessler, Ali Fattom, Raafat Fahim, Leslie Hudson